Achilles Therapeutics plc (ACHL) Misses Q3 EPS by 7c

Achilles Therapeutics plc (NASDAQ: ACHL) reported Q3 EPS of ($0.48), $0.07 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Achilles Therapeutics plc (ACHL) click here.

You May Also Be Interested In

• Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
• Us 10-year Treasury Yield Rises 10 Basis Points On Day To 5.27%
• Jefferies Financial Group (JEF) call put ratio 1 call to 1 put into quarter results